Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001674236-24-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-11 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $65.55 | -7,787 | 177.7K | -4% | -$510.4K | |
| 2024-03-11 | 2024-03-07 | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $66.71 | -4,216 | 185.5K | -2% | -$281.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | S | D | 7,787 | $65.55 | 177,712 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $65.08 to $66.63. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2024-03-07 | F | D | 4,216 | $66.71 | 185,499 | D | — | — |